GeNeuro: Financial Information and Business Update for the First Quarter 2018 – Business Wire (press release)

GeNeuro: Financial Information and Business Update for the First Quarter 2018 – Business Wire (press release)

GeNeuro: Financial Information and Business Update for the First Quarter 2018
Business Wire (press release)
GENEVA–(BUSINESS WIRE)–Regulatory News: GeNeuro (Paris:GNRO) (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurological and autoimmune diseases, including multiple sclerosis (MS) and type 1 diabetes

GeNeuro: Financial Information and Business Update for the First Quarter 2018 – Business Wire (press release)